Policy making for vaccine use as a driver of vaccine innovation and development in the developed world

Medicine and Dentistry

• Pathogen 100%
• Vaccine 100%
• Public Health 50%
• Disease 50%
• Health Care Cost 50%
• Human Immunodeficiency Virus 50%
• Infection 50%
• Cost-Effectiveness Analysis 50%
• Zika Virus 50%
• Influenza Vaccine 50%
• Pertussis 50%
• Antiinfective Agent 50%
• Disease Burden 50%
• Disease Epidemiology 50%
• Ebolavirus 50%
• Public-Private Partnership 50%
• Vaccine Development 50%
• Osteophyte 50%
• Vaccine Immunogenicity 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Infectious Agent 66%
• Infection 33%
• Antiinfective Agent 33%
• Vaccine Development 33%
• Zika Virus 33%
• HIV 33%
• Influenza Vaccine 33%
• Pertussis 33%
• Immunogenicity 33%
• Ebola Virus 33%
• Osteophyte 33%